Growth Metrics

ProQR Therapeutics N.V (PRQR) Shares Issued: 2021-2025

Historic Shares Issued for ProQR Therapeutics N.V (PRQR) over the last 2 years, with Mar 2025 value amounting to $70,476.

  • ProQR Therapeutics N.V's Shares Issued fell 59.95% to $70,476 in Q1 2025 from the same period last year, while for Mar 2025 it was $76.4 million, marking a year-over-year increase of 412.07%. This contributed to the annual value of $76.5 million for FY2024, which is 19890.40% up from last year.
  • Latest data reveals that ProQR Therapeutics N.V reported Shares Issued of $70,476 as of Q1 2025, which was down 99.91% from $76.4 million recorded in Q4 2024.
  • ProQR Therapeutics N.V's Shares Issued's 5-year high stood at $99.5 million during Q2 2021, with a 5-year trough of $1,098 in Q3 2024.
  • Its 3-year average for Shares Issued is $11.0 million, with a median of $164,377 in 2023.
  • Examining YoY changes over the last 5 years, ProQR Therapeutics N.V's Shares Issued showed a top increase of 35,564.42% in 2024 and a maximum decrease of 99.33% in 2024.
  • Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Shares Issued stood at $415,262 in 2021, then soared by 3,361.50% to $14.4 million in 2022, then slumped by 98.51% to $214,112 in 2023, then skyrocketed by 35,564.42% to $76.4 million in 2024, then plummeted by 59.95% to $70,476 in 2025.
  • Its last three reported values are $70,476 in Q1 2025, $76.4 million for Q4 2024, and $1,098 during Q3 2024.